Cobiprostone clinical trials
Also written SPI-8811.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses cobiprostone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses cobiprostone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Cobiprostone Prevention of NSAID-induced Gastroduodenal InjuryCompletedPhase 2Sucampo Pharma Americas, LLCNCT00597818Written as Cobiprostone
- Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and ChemotherapyTerminatedPhase 2Sucampo Pharma Americas, LLCNCT02542215Written as Cobiprostone
- Efficacy and Safety of Cobiprostone in Patients With Portal HypertensionTerminatedPhase 2Sucampo Pharma Americas, LLCNCT00737594Written as Cobiprostone
Codes
What other systems call cobiprostone · ClinicalTrials.gg INT006279
- MeSH (NLM) C581134cobiprostoneOne source NLM
- UNII (FDA) IL870Q3Z8ICOBIPROSTONEConfirmed FDA, NLM, Wikidata
- Wikidata Q27280783cobiprostoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C78117CobiprostoneOne source FDA
- DrugBank DB05514One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C581134 | cobiprostone | One source NLM |
| UNII (FDA) | IL870Q3Z8I | COBIPROSTONE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27280783 | cobiprostone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C78117 | Cobiprostone | One source FDA |
| DrugBank | DB05514 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.